Skip to main content

Table 1 Characteristics of included studies

From: The impact of provider restrictions on abortion-related outcomes: a synthesis of legal and health evidence

Author/year

Country

Methods

Participants

Applicable Provider Restriction

Afework 2015

Ethiopia

Individual interviews at three private health facilities

Women seeking abortion services n = 38, health extension workers n = 9, healthcare providers n = 7

No provider restrictions in legislation; determined by ministerial guidelines. Elements of CAC may be provided by gynecologists, General Practitioners (GPs), health officers, IESO and nurse midwives, nurses and health extension workers

Andersen 2016

Nepal

Program evaluation including baseline and post-training evaluation using provider progress reports and interviews

N = 290 primary level facilities providing medical abortion. Interviews with 98 healthcare providers

Provision of medical abortion expanded from physicians and staff nurses to auxiliary nurse-midwives already certified as skilled birth attendants

Battistelli 2018

United States

Individual interviews

Administrators n = 20 whose 5 organizations trained and employed healthcare providers in surgical abortion

Provision of first-trimester aspiration abortions extended to nurse practitioners, certified nurse-midwives, and physician assistants

Bridgman-Packer 2018

Ethiopia

Case study including a desk review and individual interviews

Healthcare providers n = 3, government officials n = 1, NGO staff n = 4

No provider restrictions in legislation; determined by ministerial guidelines. Elements of CAC may be provided by gynecologists, GPs, health officers, IESO and nurse midwives, nurses and health extension workers

De Moel-Mandel 2019

Australia (Victoria)

Delphi process

Healthcare providers n = 17, experts involved with or interested in medical abortion provision

Of 24 participants 17 completed 3 rounds

Prescription for medication abortion only permitted by physicians who have completed a particular online training program

Grossman 2015

United States and Australia

Legal commentary

N/A

Prescription for mifepristone limited to certified physicians (GPs who have completed online training, or obstetrician-gynecologists exempt from the online training)

Mercier 2015

North Carolina, United States

In-depth individual interviews

Abortion providers (17 physicians, 9 nurses, 1 physician assistant, 1 counsellor and 3 clinic administrators)

Women´s Right to Know Act (WRTK) which mandates that counselling is conducted by licensed medical professionals

Rasmussen 2021

Illinois, United States

In-depth interviews

19 primary care clinicians and administrators (7 family physicians, 3 nurse practitioners, 4 certified nurse midwives, 5 administrators)

Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) for mifespristone, which requires providers to be certified with the manufacturer and complete a Prescriber Agreement Form, patients to sign a Patient Agreement Form, and medication to be dispensed only in a clinical, medical office or hospital

Srinivasulu 2021

United States

Online qualitative surveys

113 primary care clinicians (67 family physicians, 17 midwives, 12 nurse practitioners or physician assistants, 9 other physician types, 8 no response)

Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) for mifespristone, which requires providers to be certified with the manufacturer and complete a Prescriber Agreement Form, patients to sign a Patient Agreement Form, and medication to be dispensed only in a clinical, medical office or hospital